A User-Friendly, Open-Source Tool to Project Impact and Costs of Diagnostic Tests for Tuberculosis David Dowdy, MD PhD June 6, 2013 Ctr for TB Research.

Slides:



Advertisements
Similar presentations
Design, prototyping and construction
Advertisements

Global Consultation on the Implementation of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB M. Akhalaia, MD, Microbiologist, Reference.
Agenda Background Current testings Xpert MTB/RIF product PAGE | 1.
High Rates of Tuberculosis in Patients Accessing HAART in Rural South Africa – Implications for HIV and TB Treatment Programs Kogieleum Naidoo on behalf.
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
Christine Lubinski Vice President for Global Health Infectious Diseases Society of America April 17, 2009 Germs Go Global Tuberculosis and HIV/TB Co-Infection.
Accelerating PMDT scale up in Ethiopia
MEASURE Evaluation M&E and Advocacy Tools in the response to the Emergency Declaration.
Monitoring and Evaluation: Tuberculosis Control Programs
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Global Plan to Stop TB Stop TB Partnership
Melbourne, 23 July IAS 2014 Fatiha Terki, WFP Critical enablers and synergies including nutrition.
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
© 2005, Johns Hopkins University. All rights reserved. Department of Health, Behavior & Society David Holtgrave, PhD, Professor & Chair.
Culture Conversion and Self- Administered Therapy in Privately Managed Tuberculosis Patients Melissa Ehman MPH, Jennifer Flood MD MPH, Pennan Barry MD.
Xpert in the diagnostic algorithm of pulmonary TB in adult patients who are neither high risk for HIV, nor high risk for MDR-TB Preparations for the global.
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
Click to edit Master title style June Custom tools for complex markets Custom software and research to support market validation for the life sciences.
HIV/AIDS: A Global and Regional Perspective AIDS in Post 2015 Development Agenda.
1 Progress report: DISCONTOOLS Project Morgane Delavergne DISCONTOOLS Project Manager, September 22nd, 2009 Mirror Group Meeting Châtelain Hotel, Brussels.
Future Incidence, Prevalence and Cost of Diabetes: An applied example of using a population prediction tool to inform public health Laura Rosella Nancy.
Using IBM Rational Unified Process for software maintenance
Potential Cost-Effectiveness of a Tuberculosis Vaccine: Implications for Clinical Trials Jared Ditkowsky Kevin Schwartzman MD, MPH Montreal Chest Institute,
Operational Research in the 21 st Century. International Union Against Tuberculosis and Lung Disease (The Union) World’s oldest humanitarian organization.
Washington D.C., USA, July 2012www.aids2012.org Estimating the Costs and Impacts of HIV/AIDS Programs for Botswana Examples of the ART Program and.
Multi-drug resistant tuberculosis: Progress and challenges in South Africa Dr S. Moyo HIV/AIDS, Sexually Transmitted Infections and TB research (HAST)Programme.
Why Use MONAHRQ for Health Care Reporting? May 2014 Note: This is one of seven slide sets outlining MONAHRQ and its value, available at
Use of routinely collected service delivery and M&E indicator data for timely feedback Denis Nash, PhD, MPH Associate Professor of Epidemiology Director,
The Research and Development Goals of the Global Plan to Stop TB Marcos Espinal Executive Secretary.
Jason Andrews, MD, SM, DTM&H Division of Infectious Diseases Massachusetts General Hospital Harvard Medical School International AIDS Society July 2, 2013.
Creating a Shared Vision Model. What is a Shared Vision Model? A “Shared Vision” model is a collective view of a water resources system developed by managers.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Group 1: HIV PREVENTION Facilitators: Ms Mai Harper Dr Stephen Kusasira.
Universal access to TB care what is the challenge, what policy, what is being implemented Cancun 3 December 2009 Léopold BLANC and TBS team TBS/STB/WHO.
NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.
PMDT expansion is first of all expansion of DR-TB detection services Workshop on the development and implementation of supervision and patient support.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
High cost of Xpert MTB/RIF ® testing per tuberculosis case diagnosed at Partners in Hope Medical Center, a public private HIV care clinic in Lilongwe,
PEPFAR Cost and Impact of Scaling Up EIMC in Southern and Eastern Africa using the DMPPT 2.0 Model AIDS 2014 – Stepping Up The Pace Emmanuel Njeuhmeli,
NAAT Is it Time for a New Option in California?. Background CDC 2009 guidelines recommend NAAT for each patient with suspected TB for whom the test result.
CHAPTER 9 COMMUNITIES AND POPULATIONS AS THE FOCUS FOR HEALTH PROMOTION PROGRAMS.
Do we need to test for isoniazid resistance? No conflict of interest Claudia Denkinger, MD PhD McGill University, Montreal Foundation for Innovative New.
The Future of Drug-Resistant TB: How Do We Prevent a Nightmare? (HINT: By Treating It!) David Dowdy, MD PhD B. Frank Polk Assistant Professor of Epidemiology.
Getting more value for money: working with countries and partners toward greater effectiveness and efficiency Peter Stegman, Senior Economist.
Introduction to decision analysis modeling Alice Zwerling, Postdoctoral fellow, JHSPH McGill TB Research Methods Course July 7, 2015.
GLOBAL TB PROGRAMME Systematic screening for active TB – operational manual and tool to help prioritization Wolfheze 2015 Knut Lönnroth, Global TB Programme.
STRATEGIC INFORMATION FOR ACTION IN VIET NAM 6 th Viet Nam National Scientific Conference 24 November 2015 Ha Noi, Viet Nam Amitabh Bipin SUTHAR, PharmD,
Revolutionizing TB Control with Innovation in New Diagnostics Dr Giorgio Roscigno Chief Executive Officer, FIND Reversing the Tide: the End of Tuberculosis,
Design, prototyping and construction(Chapter 11).
Software Evaluation Chapter 54 Introduction This is carried out when new software is need by a business. It helps the decision, of what kind of software.
Dr Justin O’Grady. Zambia is a high burden TB and high HIV setting 44,154 TB cases notified in 2010 – incidence of 462/100,000 pop Approx 48% of pulmonary.
Week 2: Interviews. Definition and Types  What is an interview? Conversation with a purpose  Types of interviews 1. Unstructured 2. Structured 3. Focus.
Global Fund Grant Proposal Round 11: Tuberculosis Nathan Furukawa Gabriella Boyle Rebekah Miner Paa Kobina Forson Xiaoxue Huang Hunter Pugh Gap Analysis.
© 2016 TM Forum Live! 2016 | 1 Anywhere Point-of-Care Diagnostics Vodafone, Cepheid, Guavus, InSTEDD, FIND.
Tuberculosis - the opportunity in our lifetime Dr. Lucica Ditiu | Executive Secretary | Stop TB Partnership 09.April.2013 | Brussels, Belgium.
Peter Cegielski, MD, MPH Team Leader for Prevention, Care and Treatment Global Tuberculosis Branch Division of Global HIV and TB Reinforcing the Surveillance.
HIV/AIDS The times they are a changing Roxana Rogers David Stanton Office of HIV/AIDS.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
World Tuberculosis Day 2016 Monitoring the implementation of the Framework Action Plan to Fight Tuberculosis in the European Union – Situation in 2014.
Monitoring and Evaluation Frameworks
Participants 18year old+
Presented by Achilles Katamba
وضعیت بیماری سل در جهان، منطقه و ایران
Design, prototyping and construction
Key issues in DOTS implementation
World Tuberculosis Day 2016
Surveillance, Monitoring and Evaluation Working Group
Design, prototyping and construction
Presentation transcript:

A User-Friendly, Open-Source Tool to Project Impact and Costs of Diagnostic Tests for Tuberculosis David Dowdy, MD PhD June 6, 2013 Ctr for TB Research Annual Meeting David Dowdy, Jason Andrews, Pete Dodd, Robert Gilman

Background Choosing between different TB diagnostic tests/algorithms is a complex task. While we have data to inform this decision, those data are not synthesized in a readily-accessible fashion. Mathematical models have been constructed, but generally do not speak to actual decision-making. –For example, “Implementation of Xpert would avert 132,000 TB cases in southern Africa over 10 years…at a cost of US$460 million” –Nice if you’re the Minister of Health of “southern Africa”… 2

Research Objective To create a user-friendly modeling tool enabling decision-makers to compare TB diagnostic strategies as deployed within an epidemic representative of local epidemiological and conditions 3

Methods Construct a steady-state TB epidemic using differential equations –In areas of low incidence or emerging MDR, allow for non-equilibrium dynamics to account for these trends Create a program that will generate this steady-state for 3 variables: –TB incidence –MDR-TB prevalence –HIV prevalence Add in costs of diagnosis and treatment –As a simple function of “cost of first-line therapy” 4

Underlying Model 5

Diagnostic Options Baseline: smear + existing array of tests Culture if Previously Treated: baseline otherwise Xpert for HIV-Positive Only: “best case” assuming perfect knowledge of HIV status Xpert if Smear-Positive: MDR-TB strategy (e.g., India) Xpert for All: Treat RIF positive as MDR Xpert for All, Culture Confirmation: Confirm RIF w/ culture MODS/TLA for All: Slower but more sensitive than Xpert Same-Day Microscopy: Eliminate “initial default,” 2x costs Same-Day Xpert: Most expansive strategy 6

User Interface 7 modeling.modeltb.org

Model Output: “High Incidence” Scenario 8

Comparing Settings 9 Delhi Baltimore

Open-Source Program Available 10

Flexible Modeling Approach: Pros Allows decision-makers to create models that are relevant to their local situations –Only a handful of TB modelers in the world, thousands of settings –Where comparisons exist, this model seems to do well Provides insight by generating comparative scenarios –More useful to play and compare than come up with “one number” –For those with more modeling expertise, program is available Transparent conclusions –Very little “modeling mumbo-jumbo” behind the scenes –Simple model, simple results: can be understood! 11

Flexible Modeling Approach: Cons Arguably too simple –Real-world complexities (e.g., level of ART availability) not included –Though code is available, few will change it Target audience difficult to define –MoH, etc., should be willing to hire technical advisors for this decision –Is this a flashy tool that nobody will end up using? Is open-source modeling dangerous? –Very few people understand the implications of model modifications –Models may be constructed that are grossly inappropriate We hope for “wikipedia-type” evolution…not guaranteed! 12

Summary Global models are useful for publishing, but locally relevant models are needed for actual decision-making. A flexible, Web-based, user-friendly model can provide users across the globe access to tailored modeling results. –Free, open-source, modifiable platform –Web-based interface –Expanding to incorporate operational characteristics as well This strategy has great potential, but also important and controversial limitations. –Our philosophy: “If we don’t try, we can’t even have the conversation.” 13

Acknowledgments Pete Dodd, LSHTM Co-Authors –Jason Andrews, MGH –Bob Gilman, JHSPH Flexible TB Modeling Team –Jonathan Golub, JHU –Dick Chaisson, JHU –Madhu Pai, McGill –Adithya Cattamanchi, UCSF Funding –NIH, R21AI